Barner H B
Division of Cardiothoracic Surgery, Washington University and Christian Hospital Northeast, St. Louis, MO, USA.
Semin Thorac Cardiovasc Surg. 1996 Jan;8(1):3-9.
Our experience with the radial artery in 172 patients from October 1993 through February 1995 has been favorable, with no early or late deaths in a group of selected patients. In 35 of the first 72 patients, the proximal anastomosis of the radial artery was to the aorta, and in all other patients it was to the left internal thoracic artery (ITA). In the first 72 patients, there were 43 right ITA grafts, 13 gastroepiploic artery grafts, and 6 saphenous vein grafts (3.57 distals per patient). In the last 100 patients, only 2 other conduits (saphenous vein) were used (in addition to left ITA and radial artery) for 3.46 distals per patient, with complete revascularization achieved in all patients requiring it. Five perioperative infarctions, 2 reoperations for bleeding, 6 intra-aortic balloon pumps, 3 instances of myocardial hypoperfusion (1 requiring a balloon pump), and 1 mediastinal wound infection were noted. Four patients required catheterization for recurrent symptoms, and all had patent radial arteries (1 from the aorta and 3 from the left ITA), but 1 ITA was stenotic at the distal anastomosis. One patient was older, with preoperative heart failure that recurred, and 2 were younger, with diffuse coronary disease. This early favorable clinical experience, when combined with the early patency data of others, suggests that continued use of this conduit is appropriate with close observation of outcome.
1993年10月至1995年2月期间,我们对172例患者使用桡动脉的经验良好,在一组选定的患者中未出现早期或晚期死亡。在前72例患者中,有35例桡动脉近端吻合至主动脉,其他所有患者的桡动脉近端吻合至左内乳动脉(ITA)。在前72例患者中,有43例使用右ITA移植物,13例使用胃网膜动脉移植物,6例使用大隐静脉移植物(每位患者平均3.57个远端吻合)。在最后100例患者中,除左ITA和桡动脉外,仅另外使用了2根血管(大隐静脉)作为移植物,每位患者平均3.46个远端吻合,所有需要血管重建的患者均实现了完全血管重建。记录到5例围手术期心肌梗死、2例因出血进行再次手术、6例使用主动脉内球囊泵、3例心肌灌注不足(1例需要球囊泵)以及1例纵隔伤口感染。4例患者因复发症状需要进行导管检查,所有患者的桡动脉均通畅(1例来自主动脉,3例来自左ITA),但1例ITA在远端吻合处狭窄。1例患者年龄较大,术前心力衰竭复发,2例患者年龄较小,患有弥漫性冠状动脉疾病。这种早期良好的临床经验,结合其他人的早期通畅数据,表明继续使用这种血管移植物是合适的,但需要密切观察结果。